Increased EID1 nuclear translocation impairs synaptic plasticity and memory function associated with pathogenesis of Alzheimer's disease

Neurobiology of Disease

Volumn 45, Issue 3, 2012, Pages 902-912

  Liu, Rugao ^a   Lei, Joy X ^b   Luo, Chun ^a   Lan, Xun ^a   Chi, Liying ^a   Deng, Panyue ^c   Lei, Saobo ^c   Ghribi, Othman ^c   Liu, Qing Yan ^b  

^a UNIVERSITY OF NORTH DAKOTA SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

^b NATIONAL RESEARCH COUNCIL CANADA   (Canada)

^c UNIVERSITY OF NORTH DAKOTA   (United States)

Author keywords

Acetylation; Alzheimer's disease; CBP p300; EP300 interacting inhibitor of differentiation 1; Histone; P53

Indexed keywords

E1A ASSOCIATED P300 PROTEIN; EP300 INTERACTING INHIBITOR OF DIFFERENTIATION 1; HISTONE; PROTEIN P53; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; ASTROCYTOSIS; BRAIN CORTEX; BRAIN DISEASE; BRAIN FUNCTION; CONTROLLED STUDY; DEVELOPMENTAL GENE; DISEASE ASSOCIATION; EID1 GENE; EMBRYO; GENE EXPRESSION; GENE OVEREXPRESSION; HIPPOCAMPUS; HISTONE ACETYLATION; HUMAN; HUMAN CELL; HUMAN TISSUE; LEARNING; LONG TERM POTENTIATION; MEMORY; MEMORY DISORDER; MOUSE; NERVE CELL; NERVE CELL PLASTICITY; NEUROFILAMENT; NONHUMAN; NUCLEAR LOCALIZATION SIGNAL; PATHOGENESIS; PRIORITY JOURNAL; SPATIAL SUMMATION;

ALZHEIMER DISEASE; ANIMALS; BRAIN; CELL LINE, TUMOR; CELL NUCLEUS; ELECTRIC STIMULATION; GLIAL FIBRILLARY ACIDIC PROTEIN; HISTONES; HUMANS; MAZE LEARNING; MEMBRANE POTENTIALS; MEMBRANE PROTEINS; MEMORY DISORDERS; MICE; MICE, TRANSGENIC; MICROTUBULE-ASSOCIATED PROTEINS; NEURONAL PLASTICITY; NEURONS; NUCLEAR PROTEINS; P300-CBP TRANSCRIPTION FACTORS; PATCH-CLAMP TECHNIQUES; PHOSPHOPROTEINS; PHOSPHOPYRUVATE HYDRATASE; PROTEIN TRANSPORT; REPRESSOR PROTEINS; TERATOCARCINOMA; TRANSFECTION; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84856562824     PISSN: 09699961     EISSN: 1095953X     Source Type: Journal    
DOI: 10.1016/j.nbd.2011.12.007     Document Type: Article

References (50)

1. Akasaka K., Maesawa C., Shibazaki M., Maeda F., Takahashi K., Akasaka T., Masuda T. Loss of class III beta-tubulin induced by histone deacetylation is associated with chemosensitivity to paclitaxel in malignant melanoma cells. J. Invest. Dermatol. 2009, 129:1516-1526.
2. Alarcon J.M., Malleret G., Touzani K., Vronskaya S., Ishii S., Kandel E.R., Barco A. Chromatin acetylation, memory, and LTP are impaired in CBP+/- mice: a model for the cognitive deficit in Rubinstein-Taybi syndrome and its amelioration. Neuron 2004, 42:947-959.
3. Austin S.A., Combs C.K. Amyloid precursor protein mediates monocyte adhesion in AD tissue and apoE(-)/(-) mice. Neurobiol. Aging 2010, 31:1854-1866.
4. Bavner A., Johansson L., Toresson G., Gustafsson J.A., Treuter E. A transcriptional inhibitor targeted by the atypical orphan nuclear receptor SHP. EMBO Rep. 2002, 3:478-484.
5. Bush J.R., Wevrick R. The Prader-Willi syndrome protein necdin interacts with the E1A-like inhibitor of differentiation EID-1 and promotes myoblast differentiation. Differentiation 2008, 76:994-1005.
6. Chen W.Y., Juan L.J., Chung B.C. SF-1 (nuclear receptor 5A1) activity is activated by cyclic AMP via p300-mediated recruitment to active foci, acetylation, and increased DNA binding. Mol. Cell. Biol. 2005, 25:10442-10453.
7. Deng P.Y., Porter J.E., Shin H.S., Lei S. Thyrotropin-releasing hormone increases GABA release in rat hippocampus. J. Physiol. 2006, 577:497-511.
8. Di G.S., Knights C.D., Rao M., Yakovlev A., Beers J., Catania J., Avantaggiati M.L., Faden A.I. The tumor suppressor protein p53 is required for neurite outgrowth and axon regeneration. EMBO J. 2006, 25:4084-4096.
9. Ekici M., Schmitz F., Hohl M., Seigel G.M., Thiel G. Chromatin structure and expression of synapsin I and synaptophysin in retinal precursor cells. Neurochem. Int. 2008, 53:165-172.
10. Fischer A., Sananbenesi F., Wang X., Dobbin M., Tsai L.H. Recovery of learning and memory is associated with chromatin remodelling. Nature 2007, 447:178-182.
11. Fischer A., Sananbenesi F., Mungenast A., Tsai L.H. Targeting the correct HDAC(s) to treat cognitive disorders. Trends Pharmacol. Sci. 2010, 31:605-617.
12. Francis Y.I., Diss J.K., Kariti M., Stephanou A., Latchman D.S. p300 activation by Presenilin 1 but not by its M146L mutant. Neurosci. Lett. 2007, 413:137-140.
13. Francis Y.I., Fa M., Ashraf H., Zhang H., Staniszewski A., Latchman D.S., Arancio O. Dysregulation of histone acetylation in the APP/PS1 mouse model of Alzheimer's disease. J. Alzheimers Dis. 2009, 18:131-139.
14. Gan L., Qiao S., Lan X., Chi L., Luo C., Lien L., Yan L.Q., Liu R. Neurogenic responses to amyloid-beta plaques in the brain of Alzheimer's disease-like transgenic (pPDGF-APPSw, Ind) mice. Neurobiol. Dis. 2008, 29:71-80.
15. Gaub P., Tedeschi A., Puttagunta R., Nguyen T., Schmandke A., Di G.S. HDAC inhibition promotes neuronal outgrowth and counteracts growth cone collapse through CBP/p300 and P/CAF-dependent p53 acetylation. Cell Death Differ. 2010, 17:1392-1408.
16. Gong B., Vitolo O.V., Trinchese F., Liu S., Shelanski M., Arancio O. Persistent improvement in synaptic and cognitive functions in an Alzheimer mouse model after rolipram treatment. J. Clin. Invest. 2004, 114:1624-1634.
17. Graham F.L., Smiley J., Russell W.C., Nairn R. Characteristics of a human cell line transformed by DNA from human adenovirus type 5. J. Gen. Virol. 1977, 36:59-74.
18. Green K.N., Steffan J.S., Martinez-Coria H., Sun X., Schreiber S.S., Thompson L.M., LaFerla F.M. Nicotinamide restores cognition in Alzheimer's disease transgenic mice via a mechanism involving sirtuin inhibition and selective reduction of Thr231-phosphotau. J. Neurosci. 2008, 28:11500-11510.
19. Gu W., Roeder R.G. Activation of p53 sequence-specific DNA binding by acetylation of the p53 C-terminal domain. Cell 1997, 90:595-606.
20. Krutzfeldt M., Ellis M., Weekes D.B., Bull J.J., Eilers M., Vivanco M.D., Sellers W.R., Mittnacht S. Selective ablation of retinoblastoma protein function by the RET finger protein. Mol. Cell 2005, 18:213-224.
21. Lee S., Walker C.L., Karten B., Kuny S.L., Tennese A.A., O'Neill M.A., Wevrick R. Essential role for the Prader-Willi syndrome protein necdin in axonal outgrowth. Hum. Mol. Genet. 2005, 14:627-637.
22. Li B., Ryder J., Su Y., Moore S.A., Liu F., Solenberg P., Brune K., Fox N., Ni B., Liu R., Zhou Y. Overexpression of GSK3betaS9A resulted in tau hyperphosphorylation and morphology reminiscent of pretangle-like neurons in the brain of PDGSK3beta transgenic mice. Transgenic Res. 2004, 13:385-396.
23. Liu Q.Y., Pandey S., Singh R.K., Lin W., Ribecco M., Borowy-Borowski H., Smith B., Leblanc J., Walker P.R., Sikorska M. DNaseY: a rat DNaseI-like gene coding for a constitutively expressed chromatin-bound endonuclease. Biochemistry 1998, 37:10134-10143.
24. Liu Q.Y., Lei J.X., Leblanc J., Sodja C., Ly D., Charlebois C., Walker P.R., Yamada T., Hirohashi S., Sikorska M. Regulation of DNaseY activity by actinin-alpha4 during apoptosis. Cell Death Differ. 2004, 11:645-654.
25. Liu Y., Hong Y., Zhao Y., Ismail T.M., Wong Y., Eu K.W. Histone H3 (lys-9) deacetylation is associated with transcriptional silencing of E-cadherin in colorectal cancer cell lines. Cancer Invest. 2008, 26:575-582.
26. Macchiarulo A., Rizzo G., Costantino G., Fiorucci S., Pellicciari R. Unveiling hidden features of orphan nuclear receptors: the case of the small heterodimer partner (SHP). J. Mol. Graph. Model. 2006, 24:362-372.
27. MacLellan W.R., Xiao G., Abdellatif M., Schneider M.D. A novel Rb- and p300-binding protein inhibits transactivation by MyoD. Mol. Cell. Biol. 2000, 20:8903-8915.
28. Maggirwar S.B., Ramirez S., Tong N., Gelbard H.A., Dewhurst S. Functional interplay between nuclear factor-kappaB and c-Jun integrated by coactivator p300 determines the survival of nerve growth factor-dependent PC12 cells. J. Neurochem. 2000, 74:527-539.
29. Marambaud P., Wen P.H., Dutt A., Shioi J., Takashima A., Siman R., Robakis N.K. A CBP binding transcriptional repressor produced by the PS1/epsilon-cleavage of N-cadherin is inhibited by PS1 FAD mutations. Cell 2003, 114:635-645.
30. Miyake S., Sellers W.R., Safran M., Li X., Zhao W., Grossman S.R., Gan J., DeCaprio J.A., Adams P.D., Kaelin W.G. Cells degrade a novel inhibitor of differentiation with E1A-like properties upon exiting the cell cycle. Mol. Cell. Biol. 2000, 20:8889-8902.
31. Morris R. Developments of a water-maze procedure for studying spatial learning in the rat. J. Neurosci. Methods 1984, 11:47-60.
32. Park Y.Y., Park K.C., Shong M., Lee S.J., Lee Y.H., Choi H.S. EID-1 interacts with orphan nuclear receptor SF-1 and represses its transactivation. Mol. Cells 2007, 24:372-377.
33. Peleg S., Sananbenesi F., Zovoilis A., Burkhardt S., Bahari-Javan S., gis-Balboa R.C., Cota P., Wittnam J.L., Gogol-Doering A., Opitz L., Salinas-Riester G., Dettenhofer M., Kang H., Farinelli L., Chen W., Fischer A. Altered histone acetylation is associated with age-dependent memory impairment in mice. Science 2010, 328:753-756.
34. Pleasure S.J., Lee V.M. NTera 2 cells: a human cell line which displays characteristics expected of a human committed neuronal progenitor cell. J. Neurosci. Res. 1993, 35:585-602.
35. Roelfsema J.H., White S.J., Ariyurek Y., Bartholdi D., Niedrist D., Papadia F., Bacino C.A., den Dunnen J.T., van Ommen G.J., Breuning M.H., Hennekam R.C., Peters D.J. Genetic heterogeneity in Rubinstein-Taybi syndrome: mutations in both the CBP and EP300 genes cause disease. Am. J. Hum. Genet. 2005, 76:572-580.
36. Rouaux C., Jokic N., Mbebi C., Boutillier S., Loeffler J.P., Boutillier A.L. Critical loss of CBP/p300 histone acetylase activity by caspase-6 during neurodegeneration. EMBO J. 2003, 22:6537-6549.
37. Saura C.A., Choi S.Y., Beglopoulos V., Malkani S., Zhang D., Shankaranarayana Rao B.S., Chattarji S., Kelleher R.J., Kandel E.R., Duff K., Kirkwood A., Shen J. Loss of presenilin function causes impairments of memory and synaptic plasticity followed by age-dependent neurodegeneration. Neuron 2004, 42:23-36.
38. Sharma S.K. Protein acetylation in synaptic plasticity and memory. Neurosci. Biobehav. Rev. 2010, 34:1234-1240.
39. Shen H., Sikorska M., Leblanc J., Walker P.R., Liu Q.Y. Oxidative stress regulated expression of ubiquitin Carboxyl-terminal Hydrolase-L1: role in cell survival. Apoptosis 2006, 11:1049-1059.
40. Sodja C., Fang H., Dasgupta T., Ribecco M., Walker P.R., Sikorska M. Identification of functional dopamine receptors in human teratocarcinoma NT2 cells. Brain Res. Mol. Brain Res. 2002, 99:83-91.
41. Tedeschi A., Di G.S. The non-apoptotic role of p53 in neuronal biology: enlightening the dark side of the moon. EMBO Rep. 2009, 10:576-583.
42. Tedeschi A., Nguyen T., Puttagunta R., Gaub P., Di G.S. A p53-CBP/p300 transcription module is required for GAP-43 expression, axon outgrowth, and regeneration. Cell Death Differ. 2009, 16:543-554.
43. Tsirigotis M., Tang M.Y., Beyers M., Zhang M., Woulfe J., Gray D.A. Delayed spinocerebellar ataxia in transgenic mice expressing mutant ubiquitin. Neuropathol. Appl. Neurobiol. 2006, 32:26-39.
44. Valor L.M., Pulopulos M.M., Jimenez-Minchan M., Olivares R., Lutz B., Barco A. Ablation of CBP in forebrain principal neurons causes modest memory and transcriptional defects and a dramatic reduction of histone acetylation but does not affect cell viability. J. Neurosci. 2011, 31:1652-1663.
45. Vecsey C.G., Hawk J.D., Lattal K.M., Stein J.M., Fabian S.A., Attner M.A., Cabrera S.M., McDonough C.B., Brindle P.K., Abel T., Wood M.A. Histone deacetylase inhibitors enhance memory and synaptic plasticity via CREB:CBP-dependent transcriptional activation. J. Neurosci. 2007, 27:6128-6140.
46. Vitolo O.V., Sant'Angelo A., Costanzo V., Battaglia F., Arancio O., Shelanski M. Amyloid beta -peptide inhibition of the PKA/CREB pathway and long-term potentiation: reversibility by drugs that enhance cAMP signaling. Proc. Natl. Acad. Sci. U. S. A. 2002, 99:13217-13221.
47. Vo N., Goodman R.H. CREB-binding protein and p300 in transcriptional regulation. J. Biol. Chem. 2001, 276:13505-13508.
48. Wen H., Ao S. Identification and characterization of a novel human cDNA encoding a 21 kDa pRb-associated protein. Gene 2001, 263:85-92.
49. Xu W., Chi L., Row B.W., Xu R., Ke Y., Xu B., Luo C., Kheirandish L., Gozal D., Liu R. Increased oxidative stress is associated with chronic intermittent hypoxia-mediated brain cortical neuronal cell apoptosis in a mouse model of sleep apnea. Neuroscience 2004, 126:313-323.
50. Yukawa K., Tanaka T., Tsuji S., Akira S. Regulation of transcription factor C/ATF by the cAMP signal activation in hippocampal neurons, and molecular interaction of C/ATF with signal integrator CBP/p300. Brain Res. Mol. Brain Res. 1999, 69:124-134.